Treatment with lamivudine for non-immunocompromized patients with chronic hepatitis B.
Frederik
N
N
D002986:Clinical Trials as Topic; D004279:DNA, Viral / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D006515:Hepatitis B virus / Q000187:drug effects* / Q000276:immunology; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007121:Immunocompetence; D019259:Lamivudine / Q000008:administration & dosage*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D016896:Treatment Outcome
D004279:DNA, Viral; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine